In renal clear cell carcinoma and thyroid carcinoma, EpCAM expression has been correlated with improved survival, and in lung cancer, EpCAM overexpression was also associated with improved (Baeuerle and Gires 2007) or not worse prognosis (Kim et al. 2009). Here, EPCAM is linked to thyroid gland carcinoma.